SCHEMBL6777804

SCHEMBL6777804

O=C(Cc1cccnc1)CN1CCCC1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.50
TSHR P16473 2/20 0.50
NAPRT Q6XQN6 1/20 0.48
HTT P42858 1/20 0.46
NAMPT P43490 2/20 0.45
LMNA P02545 1/20 0.44
TNKS O95271 1/20 0.44
PARP1 P09874 1/20 0.44
PARP2 Q9UGN5 1/20 0.44
PARP4 Q9UKK3 1/20 0.44
PARP3 Q9Y6F1 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CHRNB2 P17787 1/20 0.42
CHRNA4 P43681 1/20 0.42
FNTA P49354 1/20 0.42
FNTB P49356 1/20 0.42
CYP17A1 P05093 1/20 0.41
CYP19A1 P11511 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6776347 0.84 ALDH1A1 (0.45) ALDH1A1TSHRNAPRTHTTNAMPT
SCHEMBL6776344 0.84 ALDH1A1 (0.45) ALDH1A1TSHRNAPRTHTTNAMPT
SCHEMBL7287505 0.80 L3MBTL1 (0.58) ALDH1A1TSHRHTTNAMPTLMNA
SCHEMBL6766324 0.80 TSHR (0.42) ALDH1A1TSHRNAPRTHTTNAMPT
SCHEMBL6766329 0.80 TSHR (0.42) ALDH1A1TSHRNAPRTHTTNAMPT
Hydrochloric Acid SCHEMBL5578157 0.79 L3MBTL1 (0.56) ALDH1A1TSHRHTTNAMPTLMNA
SCHEMBL6771215 0.78 ALDH1A1 (0.61) ALDH1A1TSHRHTTPORCNMAPT
SCHEMBL6769690 0.77 HTT (0.40) ALDH1A1TSHRNAPRTHTTNAMPT
SCHEMBL6770009 0.77 HTT (0.40) ALDH1A1TSHRNAPRTHTTNAMPT
SCHEMBL6775638 0.76 HTT (0.71) ALDH1A1TSHRHTTCYP3A4PORCN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716857-B2 1-(3-HYDROCARBYLOXYIMINO-3-(1-ALKYL-1,2,5,6-TETRAHYDROPYRID-3-YL) -ALKYLPYRROLIDIN-2-ONE DERIVATIVES; RECEPTIVITY; ANALGESICS, GLAUCOMA, PSYCHOSIS, SCHIZOPHRENIA, ANXIOLYTIC AGENTS, BIPOLAR DISORDERS; ANTIDEPRESSANTS; SLEEP DISORDERS KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2004-04-06 US disclosed
US-20030119880-A1 Tetrahydropyridine derivatives acting on muscarinic acetylcholine receptors KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2003-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030119880-A1 Tetrahydropyridine derivatives acting on muscarinic acetylcholine receptors CHRM1, CHRM3, CHRM2 ALDH1A1 596/4885TSHR 92/4885NAPRT 2300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.